SEC Form 4 · accession 0001225208-15-008458
CORCEPT THERAPEUTICS INC · CORT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
G Leonard Baker Jr.
Director
Period of report
Mar 20, 2015
Accepted (ET)
Mar 24, 2015 · 6:16 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001088856
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Mar 20, 2015 | X | 68,224 | $2.77 | A | 2,029,343 | I | By Ltd Partnership |
| Common StockF2,F1 | Mar 20, 2015 | S | 32,305 | $5.85 | D | 1,997,038 | I | By Ltd Partnership |
| Common StockF3 | Mar 20, 2015 | X | 364,821 | $2.77 | A | 5,681,788 | I | By Ltd Partnership (SHV) |
| Common StockF2,F3 | Mar 20, 2015 | S | 172,745 | $5.85 | D | 5,509,043 | I | By Ltd Partnership (SHV) |
| Common StockF4 | Mar 20, 2015 | X | 230,841 | $2.77 | A | 1,061,819 | I | By Trust |
| Common StockF2,F4 | Mar 20, 2015 | S | 109,306 | $5.85 | D | 952,513 | I | By Trust |
| Common Stock | holding | — | — | — | 578,389 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock WarrantF1,F5 | $2.77 | Mar 20, 2015 | X | 68,224 | D | — | Mar 24, 2015 | Common Stock | 68,224 | 0 | I |
| Common Stock WarrantF3,F5 | $2.77 | Mar 20, 2015 | X | 364,821 | D | — | Mar 24, 2015 | Common Stock | 364,821 | 0 | I |
| Common Stock WarrantF4,F5 | $2.77 | Mar 20, 2015 | X | 230,841 | D | — | Mar 24, 2015 | Common Stock | 230,841 | 0 | I |
Explanation of responses
- F1Shares held by a limited partnership of which the reporting person is a trustee of a trust which is the General Partner. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest therein.
- F2On March 20, 2015, the reporting person exercised warrants to purchase shares of the issuer's common stock for $2.77 per share. In accordance with the terms of the warrants, the exercise price was paid on a net basis. The shares disposed of in column 4 represent the number of shares of common stock withheld by the issuer to pay the exercise price.
- F3Shares held by Sutter Hill Ventures, a California Limited Partnership. The reporting person is a Managing Director of the General Partner of Sutter Hill Ventures, a California Limited Partnership. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest in the partnership.
- F4Shares held by a trust of which the reporting person is a trustee. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest in the trust.
- F5Immediate.